Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to Insider Trades Newsletter so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.
Send Confirmation Email

Impel Pharmaceuticals (IMPL) Earnings Date, Estimates & Call Transcripts

→ Read this before you buy AI stocks (From InvestorPlace) (Ad)
Free IMPL Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Stock AnalysisEarningsHeadlinesInsider TradesOwnershipShort InterestSocial Media
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

IMPL Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

IMPL Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Impel Pharmaceuticals Analyst EPS Estimates

Current Year EPS Consensus Estimate:($3.40) EPS
Next Year EPS Consensus Estimate: ($1.10) EPS

Impel Pharmaceuticals Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/14/2023Q3 2023-($0.58)($0.58)($0.58)-$5.02 million
8/18/2023Q2 2023-($0.31)($0.31)($0.31)-$6.58 million
5/12/2023Q1 2023-($1.27)($1.27)($1.27)-$4.37 million
3/24/2023Q4 2022($1.04)($0.97)+$0.07($0.97)$4.06 million$5.01 million
11/14/2022Q3 2022($0.87)($1.31)($0.44)($1.31)$5.16 million$3.08 million
8/15/2022Q2 2022($1.13)($1.09)+$0.04($1.09)$2.72 million$2.80 million
This Could be Your “Big Money” AI Moment (Ad)

BREAKING: New "Formula" Could Lead to Huge AI Payouts When you click here and see what Elon Musk's new invention does… Investors — including multiple billionaires — are now tapping into a unique AI secret to pocket huge, consistent payouts.

Starting today, you could siphon a new stream of income from this $3 billion pool of cash.
5/16/2022Q1 2022($1.08)($1.17)($0.09)($1.17)$1.60 million$1.76 million
3/24/2022Q4 2021($0.86)($1.07)($0.21)($1.07)$1.89 million$0.58 million    
11/15/2021Q3 2021($0.82)($1.24)($0.42)($1.24)-$0.09 million    
8/16/2021Q2 2021($0.60)($0.79)($0.19)($0.48)--    
6/6/2021Q1 2021($0.93)($0.54)+$0.39$14.01--

Impel Pharmaceuticals Earnings - Frequently Asked Questions

How much revenue does Impel Pharmaceuticals generate each year?

Impel Pharmaceuticals (NASDAQ:IMPL) has a recorded annual revenue of $20.99 million.

How much profit does Impel Pharmaceuticals generate each year?

Impel Pharmaceuticals (NASDAQ:IMPL) has a recorded net income of -$106.31 million. IMPL has generated -$3.13 earnings per share over the last four quarters.

What is Impel Pharmaceuticals's EPS forecast for next year?

Impel Pharmaceuticals's earnings are expected to grow from ($3.40) per share to ($1.10) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:IMPL) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
"The Biggest Drug Ever" Is Coming
Behind the Markets
Exposed: 10 CENT Crypto to Explode May 20th?
True Market Insiders
The 2024 Gold Rush: Unleashing Market Potential
Priority Gold
**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1!
Huge Alerts
Warren Buffett's "mystery stock"
Stansberry Research
This Could be Your “Big Money” AI Moment
InvestorPlace
Digitizing the $11T commodities sector with one tiny stock
Resource Stock Digest
Elon to Transform U.S. Economy?
Porter & Company